Clinical Trial Update: The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the effect of denosumab on the pharmacokinetics of midazolam in postmenopausal osteoporosis patients has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Midazolam (Midazolam)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2013-11-07